MELIOIDOSIS IN MYANMAR: FORGOTTEN BUT NOT GONE?

6 downloads 0 Views 70KB Size Report
Burkholderia pseudomallei, the cause of melioidosis. Antibodies were detectable by indirect hemagglutination assay. (IHA) in 757 (78%) of 968 adults, of whom ...
Am. J. Trop. Med. Hyg., 75(5), 2006, pp. 945–946 Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

SHORT REPORT: MELIOIDOSIS IN MYANMAR: FORGOTTEN BUT NOT GONE? VANAPORN WUTHIEKANUN, SAYAN LANGA, WITAYA SWADDIWUDHIPONG, WILARAT JEDSADAPANPONG, YINGYOT KAENGNET, WIRONGRONG CHIERAKUL, NICHOLAS P. DAY, AND SHARON J. PEACOCK* The Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Program, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Mae Sot General Hospital, Tak, Thailand; Center for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Abstract. A serologic survey of adults resident in Myanmar was conducted to define the presence of antibodies to Burkholderia pseudomallei, the cause of melioidosis. Antibodies were detectable by indirect hemagglutination assay (IHA) in 757 (78%) of 968 adults, of whom 69 (7%) had an IHA titer ⱖ 1:160. dian and inter-quartile range and analyzed using the MannWhitney U test or Kruskal-Wallis test. Ethical approval for this study was obtained from the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Sera were obtained from 968 adults, of whom 464 (48%) were men. Age ranged from 12 to 84 years (median ⳱ 26 years, inter-quartile range [IQR] ⳱ 22–33 years). The region of residence was recorded for 905 adults; most (893 of 905) lived in one of four neighboring regions in Myanmar (Kayin State, n ⳱ 429; Mon State, n ⳱ 260; Bago Division, n⳱ 103; and Yangon Division, n⳱ 101). The IHA titer for the population ranged from 0 to 1:5,120 (median ⳱ 1:20, IQR ⳱ 1: 10–1:40) (Figure 1). The proportion of adults with any detectable titer was 78% (757 of 968). The IHA results were not significantly different for people resident in the four regions (P ⳱ 0.07). Women had a significantly higher IHA titer than men (P ⳱ 0.0001). Information on occupation was available for 852 adults. Most (785 of 852, 92%) had a non-agricultural occupation. The IHA titers of agricultural workers and nonagricultural workers were not significantly different (P ⳱ 0.25). An IHA titer ⱖ 1:160 is commonly used in Thailand to support a diagnosis of melioidosis in patients with clinical features consistent with this diagnosis. Sixty-nine (7%) adults in this study had an IHA titer ⱖ 1:160. Serologic surveys indicate that a high proportion of the population resident within melioidosis-endemic areas develop an antibody response to B. pseudomallei. In Thailand, the proportion with any detectable response as defined by the IHA is comparable for resident populations in areas of high and low endemicity for melioidosis. For example, the proportion of children in highly endemic northeast Thailand (incidence of melioidosis ⳱ 137.9/100,000 hospital admissions13) with detectable antibodies to B. pseudomallei increases sharply in the first four years of life, after which at least 60% of the population are antibody positive.7 The background seropositivity rate in healthy individuals in low endemicity areas such as southern Thailand (incidence of melioidosis ⳱ 14.4/ 100,000 hospital admissions13) is comparable at approximately 58%.14 However, the proportion with a high titer (defined as ⱖ1:160) is different between the two regions; 33% of adult patients admitted to a hospital in northeast Thailand with a diagnosis other than melioidosis had IHA titers ⱖ 1:160 compared with 7–10% coming to a hospital in southern Thailand.14 In light of these observations, it is possible that the proportion of the population with an IHA titer ⱖ 1:160 who do not have clinical manifestations of melioidosis represents an indirect indication of disease frequency. The rate of seropositivity for the population of Myanmar adults in this study indicates that exposure to B. pseudomallei

Burkholderia pseudomallei is the cause of melioidosis, a severe and often fatal human infection.1,2 This organism is present in the environment over a large area of the Far East, where infection is acquired after bacterial inoculation or inhalation.2,3 Melioidosis shows a wide range of clinical manifestations, and diagnostic confirmation depends upon isolation of B. pseudomallei from clinical specimens.4,5 Serologic testing has low diagnostic specificity for melioidosis in the disease-endemic setting, where the rate of background seropositivity in the healthy population is high.6,7 However, seroprevalence studies provide evidence for exposure of a given population to B. pseudomallei, and may act as a crude indicator of the risk of infection. The first reported case of melioidosis occurred in a 40-yearold morphine addict in Rangoon (Yangon), Burma (Myanmar) in 1911. The diagnosis was made on the basis of a postmortem examination and supported by careful microbiologic investigation.8,9 By 1917, more than 100 cases had been reported in Rangoon, accounting for 5% of all post-mortem examinations.10 Cases of indigenous disease in Burma (Myanmar) have not been reported in the literature since 1945,2 but it is likely that melioidosis continues to occur. This is supported by a more recent case report of melioidosis in a traveler returning from Myanmar.11 The aim of this study was to define the rate of seropositivity in a group of adult migrant workers entering Thailand from Myanmar, and to confirm that exposure to B. pseudomallei continues unabated. A prospective, cross-sectional study was conducted between June and July 2005 during which unselected consecutive serum samples from adult migrant workers who came to Mae Sot Hospital in Tak, Thailand for a pre-employment medical examination were collected from the biochemistry department. An anonymous database was created to record sex, age, occupation (defined as agricultural or nonagricultural), and region (division or state) of residence. The presence and titer of antibodies to B. pseudomallei were defined using the indirect hemagglutination assay (IHA) as previously described,12 using pooled antigens prepared from B. pseudomallei clinical isolates 199a and 207a cultured from patients with melioidosis in northeast Thailand. Any detectable IHA titer was interpreted as evidence of exposure to B. pseudomallei. Statistical analysis was performed using the statistical program Intercooled Stata version 8.0 (Stata Corporation, College Station, TX). Data are presented using me-

* Address correspondence to Sharon J. Peacock, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok, 10400, Thailand. E-mail: [email protected]

945

946

WUTHIEKANUN AND OTHERS

REFERENCES

FIGURE 1. Detection of antibodies to Burkholderia pseudomallei by indirect hemagglutination assay (IHA) in 968 adults resident in Myanmar.

is common. A detailed travel history was not obtained and it is possible that exposure occurred elsewhere. However, most were not actively engaged in occupations in Thailand associated with environmental exposure. We suggest that exposure has predominantly occurred within Myanmar; this is consistent with historical records detailing cases of melioidosis in Yangon.8–10 The current incidence rate of melioidosis in Myanmar is unknown. The proportion of adults in this study with an IHA titer ⱖ1:160 is comparable to that for low endemicity areas of Thailand, but historical records are more in keeping with high endemicity. We propose that melioidosis remains a significant human pathogen in Myanmar, but delineation of the true incidence awaits the introduction of diagnostic culture for individuals with suspected disease. Received June 14, 2006. Accepted for publication July 24, 2006. Acknowledgments: We thank Kanoknat Pitsutikul (Hospital Director) and other staff members at Mae Sot Hospital for their support, Premjit Amornchai for technical assistance, and other members of the Wellcome Trust-Oxford University-Mahidol University Tropical Medicine Research Program for their support. Financial support: This study was supported by the Wellcome Trust Sharon J. Peacock is supported by a Wellcome Trust Career Development Award in Clinical Tropical Medicine. Authors’ addresses: Vanaporn Wuthiekanun, Sayan Langa, Wilarat Jedsadapanpong, Wirongrong Chierakul, Nicholas P. Day, and Sharon J. Peacock, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok, 10400, Thailand, Telephone: 66-2-3549172, Fax: 66-2-354-9169, E-mail: [email protected]. Witaya Swaddiwudhipong and Yingyot Kaengnet, Mae Sot General Hospital, Tak, Thailand, Telephone: 66-5-554-2337, Fax: 66-5-553-3046, Email: [email protected].

1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, Looareesuwan S, Pitakwatchara N, 1989. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 159: 890–899. 2. White NJ, 2003. Melioidosis. Lancet 361: 1715–1722. 3. Chierakul W, Winothai W, Wattanawaitunechai C, Wuthiekanun V, Rugtaengan T, Rattanalertnavee J, Jitpratoom P, Chaowagul W, Singhasivanon P, White NJ, Day NP, Peacock SJ, 2005. Melioidosis in 6 Tsunami survivors in southern Thailand. Clin Infect Dis 41: 982–990. 4. Peacock SJ, Chieng G, Cheng AC, Dance DA, Amornchai P, Wongsuvan G, Teerawattanasook N, Chierakul W, Day NP, Wuthiekanun V, 2005. Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 43: 5359–5361. 5. Walsh AL, Wuthiekanun V, 1996. The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249–253. 6. Cheng AC, Peacock SJ, Limmathurotsakul D, Wongsuvan G, Chierakul W, Amornchai P, Getchalarat N, Chaowagul W, White NJ, Day NP, Wuthiekanun V, 2006. Prospective evaluation of a rapid immunochromogenic cassette test for the diagnosis of melioidosis in northeast Thailand. Trans R Soc Trop Med Hyg 100: 64–67. 7. Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, Naigowit P, Dance DA, Smith MD, White NJ, 1993. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1,000 hospitalized children in northeast Thailand. J Infect Dis 167: 230–233. 8. Whitmore A, Krishnaswami CS, 1912. An account of the discovery of a hitherto underscribed infective disease occurring among the population of Rangoon. Indian Med Gaz 47: 262– 267. 9. Whitmore A, 1913. An account of a glanders-like disease occurring in Rangoon. J Hyg (Lond) 13: 1–34. 10. Krishnaswami CS, 1917. Morphia injectors’ septicaemia. Indian Med Gaz 52: 296–299. 11. Lee SC, Ling TS, Chen JC, Huang BY, Sheih WB, 1999. Melioidosis with adrenal gland abscess. Am J Trop Med Hyg 61: 34–36. 12. Alexander AD, Huxsoll DH, Warner ARJ, Shepler V, Dorsey A, 1970. Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests. Appl Microbiol 20: 825–833. 13. Vuddhakul V, Tharavichitkul P, Na-Ngam N, Jitsurong S, Kunthawa B, Noimay P, Binla A, Thamlikitkul V, 1999. Epidemiology of Burkholderia pseudomallei in Thailand. Am J Trop Med Hyg 60: 458–461. 14. Wuthiekanun V, Chierakul W, Rattanalertnavee J, Langa S, Sirodom D, Wattanawaitunechai C, Winothai W, White NJ, Day N, Peacock SJ, 2006. Serological evidence for increased human exposure to Burkholderia pseudomallei following the tsunami in southern Thailand. J Clin Microbiol 44: 239–240.